News and Events

The largest retrospective study on antibiotic resistance (AMR) in Africa highlights the need for major investments to enhance laboratory capabilities and healthcare access.

The threat of mortality, morbidity, and economic loss associated with antimicrobial resistance (AMR) poses a significant burden on countries in the South East Asia region.

Two landmark projects aimed at strengthening the Caribbean’s capacity to fight antimicrobial resistance (AMR) were launched on 5 May, at an event in Barbados with regional and international health leaders in attendance.

A free online programme developed by the Fleming Fund and The Open University to strengthen the global response to antimicrobial resistance (AMR) has been relaunched with updated content across all 25 courses.

A major driver of AMR is the inappropriate use of antimicrobials. This is a common issue in many resource-limited countries with poor access to the correct medicines and treatment.

A new Regional Grant for phase 2 of the Fleming Fund, GEAR up (Gender and Equity within Antimicrobial Resistance) is led by the Liverpool School of Tropical Medicine (LSTM) in the UK.

The Burnet Institute, Fleming Fund Country Grant lead for Papua New Guinea, unveiled two national AMR laboratories, marking a significant milestone for PNG healthcare.

The fifth Fleming Fellows Symposium welcomed the new phase 2 fellows, Fleming alumni, and the Africa Leadership Antimicrobial Stewardship (ALF-A) fellows from the Commonwealth Pharmacy Association.

The GRAM project led by Institute for Health Metrics and Evaluation and the University of Oxford and funded by the UK Department of Health and Social Care’s Fleming Fund and Wellcome, released the latest GRAM paper, published in The Lancet.